In this presentation, we will describe concerns related to global and national multidrug resistant tuberculosis (MDR TB) epidemiology. We will also review key steps in prevention, diagnosis, and treatment. Important challenges faced by Canadian public health systems in responding to MDR TB and solutions to support people who are affected will also be discussed.
Multidrug resistant TB (MDR TB) is a potentially fatal and difficult to treat infectious disease. Incidence in Canada is low but is may increase in coming years. Managing MDR TB presents several challenges for public health systems and places an enormous burden on those affected and their families.
- Participants will gain a deeper understanding of why MDR TB is a serious threat to public health in Canada.
- Participants will learn about key challenges for the Canadian response to MDR TB.
- Participants will increase awareness of solutions to reduce MDR TB incidence in Canada and to support people affected and their families.
This webinar will be delivered in English. The presentation will be followed by a Q&A session.
Nancy Bedingfield, Project Manager
Dr. Brett Edwards is a clinician and researcher in the Division of Infectious Diseases at the University of Calgary. He completed his subspecialty medicine training in Infectious Diseases before obtaining a Clinical and Research Fellowship in Mycobacterial Disease at the University of Toronto and West Park Health Care Centre. He obtained further clinical training in TB, including drug-resistant TB, at the Groote Schuur Hospital in Cape Town, South Africa, which sees some of the highest rates of MDR-TB worldwide. He currently works with Calgary TB Services, which works directly with Public Health in Alberta, in addition to Clinical Infectious Diseases, and the Nontuberculous Mycobacterial Program at the University of Calgary.